SCHEMBL154607

SCHEMBL154607

O=C(c1ccccc1)N(CCO)CCO

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.53
ALDH1A1 P00352 3/20 0.53
LIMK2 P53671 1/20 0.50
MAPT P10636 1/20 0.48
L3MBTL1 Q9Y468 3/20 0.47
HDAC1 Q13547 3/20 0.46
HDAC6 Q9UBN7 3/20 0.46
HDAC3 O15379 2/20 0.46
HDAC7 Q8WUI4 2/20 0.46
HDAC10 Q969S8 2/20 0.46
HDAC8 Q9BY41 2/20 0.46
HDAC4 P56524 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45
HDAC5 Q9UQL6 1/20 0.45
GAA P10253 1/20 0.45
CYP3A4 P08684 1/20 0.45
KMT2A Q03164 2/20 0.44
ADRA2C P18825 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27871652 0.98 HPGD (0.52) HPGDALDH1A1LIMK2MAPTL3MBTL1
SCHEMBL7157289 0.89 ALDH1A1 (0.48) HPGDALDH1A1LIMK2MAPTL3MBTL1
SCHEMBL8615545 0.88 LIMK2 (0.63) ALDH1A1LIMK2L3MBTL1HDAC1HDAC6
SCHEMBL1003828 0.88 HPGD (0.66) HPGDALDH1A1MAPTL3MBTL1HDAC1
SCHEMBL7543305 0.86 HPGD (0.43) HPGDALDH1A1LIMK2MAPTL3MBTL1
SCHEMBL10925719 0.85 HPGD (0.56) HPGDALDH1A1HDAC1HDAC6HDAC3
SCHEMBL1246672 0.83 HDAC3 (0.45) HPGDALDH1A1LIMK2MAPTL3MBTL1
SCHEMBL21788015 0.83 ALDH1A1 (0.53) HPGDALDH1A1LIMK2MAPTL3MBTL1
SCHEMBL9526328 0.82 ADRA2C (0.54) HPGDALDH1A1LIMK2L3MBTL1HDAC1
SCHEMBL3401575 0.81 AKR1C3 (0.53) HPGDALDH1A1MAPTGAATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 284 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1817042-A2 GLYCERIN BASED SYNTHESIS OF SILVER NANOPARTICLES AND NANOWIRES Board of Regents, The University of Texas System (US) 2007-08-15 EP claimed
WO-2007001453-A9 GLYCERIN BASED SYNTHESIS OF SILVER NANOPARTICLES AND NANOWIRES UNIV TEXAS (US) 2007-03-01 WO claimed
WO-2007001453-A2 GLYCERIN BASED SYNTHESIS OF SILVER NANOPARTICLES AND NANOWIRES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYTEM (US) 2007-01-04 WO claimed
US-20060115536-A1 Glycerin based synthesis of silver nanoparticles and nanowires BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2006-06-01 US claimed
US-20030119931-A1 Novel spiroorthocarbonates THE CURATORS OF THE UNIVERSITY OF MISSOURI 2003-06-26 US claimed
US-6458865-B2 FOR DENTAL RESTORATION MATERIAL CURATORS OF THE UNIVERSITY OF MISSOURI 2002-10-01 US claimed
EP-1165627-A4 PHOTOPOLYMERIZABLE VINYL ETHER BASED MONOMERIC FORMULATIONS AND POLYMERIZABLE COMPOSITIONS WHICH MAY INCLUDE CERTAIN NOVEL SPIROORTHOCARBONATES UNIV MISSOURI (US) 2002-03-20 EP claimed
US-20020013380-A1 PHOTOPOLYMERIZABLE VINYL ETHER BASED MONOMERIC FORMULATIONS AND POLYMERIZABLE COMPOSITIONS WHICH MAY INCLUDE CERTAIN NOVEL SPIROORTHOCARBONATES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-01-31 US claimed
EP-1165627-A1 PHOTOPOLYMERIZABLE VINYL ETHER BASED MONOMERIC FORMULATIONS AND POLYMERIZABLE COMPOSITIONS WHICH MAY INCLUDE CERTAIN NOVEL SPIROORTHOCARBONATES THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) 2002-01-02 EP claimed
WO-2000042080-A1 PHOTOPOLYMERIZABLE VINYL ETHER BASED MONOMERIC FORMULATIONS AND POLYMERIZABLE COMPOSITIONS WHICH MAY INCLUDE CERTAIN NOVEL SPIROORTHOCARBONATES THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) 2000-07-20 WO claimed
EP-4514304-B1 DENTAL COMPOSITION CONTAINING A RESORCINOL OR CATECHOL MOIETY CONTAINING COMPONENT AND USE THEREOF SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2026-03-25 EP disclosed
US-12516147-B2 Aldimines and uses thereof BOSTIK SA (FR) 2026-01-06 US disclosed
US-12311037-B2 Dental composition containing a resorcinol or catechol moiety containing component and use thereof SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-05-27 US disclosed
US-20250114283-A1 Dental Composition Containing a Resorcinol or Catechol Moiety Containing Component and Use Thereof SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2025-04-10 US disclosed
EP-4077273-B1 ALDIMINES AND USES THEREOF BOSTIK SA (FR) 2025-04-02 EP disclosed
US-4218531-A AROMATIC SULFONIUM COMPLEX SALT PHOTOINITIATOR MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1980-08-19 US disclosed
US-4173476-A TRIARYLULFONIUM HEXAFLUOROANTIMONATE OR HYDROXYPENTAFLUOROANTIMONATE, PHOTOPOLYMERIZATION OF EPOXIDE MONOMERS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1979-11-06 US disclosed
US-4115295-A EPOXIDE FUNCTIONAL, HYDROXY FUNCTIONAL, DIELECTRICS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1978-09-19 US disclosed
US-4017522-A MICROBIOCIDES THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1977-04-12 US disclosed
US-3932324-A NICKEL COMPLEXES WITH 2,2-THIOBIS(ALKYLPHENOL), HYDROXYALKYLAMIDES AMERICAN CYANAMID COMPANY (US) 1976-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12311037-B2 Dental composition containing a resorcinol or catechol moiety containing component and use thereof RDX, RECQL, RHOC HPGD 460/4885ALDH1A1 1964/4885LIMK2 3491/4885
US-20250114283-A1 Dental Composition Containing a Resorcinol or Catechol Moiety Containing Component and Use Thereof RDX, RECQL, RABGGTB HPGD 472/4885ALDH1A1 2001/4885LIMK2 3475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.